Singapore markets closed

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
19.340-0.240 (-1.23%)
At close: 04:08PM HKT

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

No. 45, Shamian North Street
Liwan District
Guangzhou 510130
China
86 20 6628 1011
https://www.gybys.com.cn

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees28,048

Key executives

NameTitlePayExercisedYear born
Mr. Chuyuan LiExecutive ChairmanN/AN/A1966
Mr. Hong LiGM & Executive Director1.63MN/A1967
Ms. Ning ChengVice ChairmanN/AN/A1966
Mr. Jun YangVice ChairmanN/AN/A1970
Mr. Changhai WuDeputy GM & Executive Director411.84kN/A1966
Ms. Juyan LiuExecutive DirectorN/AN/A1964
Mr. Zhang ChunboDeputy GM & Executive Director325.54kN/A1977
Ms. Haoshan ZhengDeputy GM & Director of Business Administration DepartmentN/AN/A1976
Ms. Xuezhen HuangSecretaryN/AN/A1974
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, and medical devices; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, Guiling jellies, etc. In addition, the company invests in health industry, such as medical services, health management, health care, elderly care, etc.; and provides business and advertising agency services. It operates retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Corporate governance

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 9; Board: 4; Shareholder rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.